CORC  > 中国医学科学院 北京协和医学院
Efficacy and safety of tadalafil 5 mg once-daily in Asian men with both lower urinary tract symptoms associated with benign prostatic hyperplasia and erectile dysfunction: A phase 3, randomized, double-blind, parallel, placebo- and tamsulosin-con
Zhang, Zhichao; Li, Hanzhong; Zhang, Xiaodong; Dai, Yutian; Park, Hyun Jun; Jiann, Bang-Ping; Li, Peng; Lou, Ying; Ye, Zhangqun; Viktrup, Lars
2019
卷号26期号:2页码:192-200
关键词Asia erectile dysfunction lower urinary tract symptoms prostatic hyperplasia tadalafil
ISSN号0919-8172
DOI10.1111/iju.13828
URL标识查看原文
收录类别SCIE ; PUBMED
内容类型期刊论文
URI标识http://www.corc.org.cn/handle/1471x/6346042
专题中国医学科学院 北京协和医学院
推荐引用方式
GB/T 7714
Zhang, Zhichao,Li, Hanzhong,Zhang, Xiaodong,et al. Efficacy and safety of tadalafil 5 mg once-daily in Asian men with both lower urinary tract symptoms associated with benign prostatic hyperplasia and erectile dysfunction: A phase 3, randomized, double-blind, parallel, placebo- and tamsulosin-con[J],2019,26(2):192-200.
APA Zhang, Zhichao.,Li, Hanzhong.,Zhang, Xiaodong.,Dai, Yutian.,Park, Hyun Jun.,...&Viktrup, Lars.(2019).Efficacy and safety of tadalafil 5 mg once-daily in Asian men with both lower urinary tract symptoms associated with benign prostatic hyperplasia and erectile dysfunction: A phase 3, randomized, double-blind, parallel, placebo- and tamsulosin-con.,26(2),192-200.
MLA Zhang, Zhichao,et al."Efficacy and safety of tadalafil 5 mg once-daily in Asian men with both lower urinary tract symptoms associated with benign prostatic hyperplasia and erectile dysfunction: A phase 3, randomized, double-blind, parallel, placebo- and tamsulosin-con".26.2(2019):192-200.
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace